This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatocellular Carcinoma
and you are
between 20 and 69
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This study aims to test the efficacy of combined radiotherapy and sorafenib in patients with locally advanced hepatocellular carcinoma.

Provided treatments

  • Other: Radiotherapy combined with sorafenib

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01319942. The sponsor of the trial is China Medical University Hospital and it is looking for 45 volunteers for the current phase.
Official trial title:
Combined Radiotherapy and Sorafenib in Patients With Hepatoma